19 May 2013
Keywords: osi, grants, patent, rights, merck, co, pharmaceuticals
Article | 11 July 2005
OSI Pharmaceuticals says that its diabetes and obesity business unit Prosidion, has granted fellow US firm Merck & Co a worldwide,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 July 2005
17 May 2013
© 2013 thepharmaletter.com